Cure Pharmaceutical Holding CorpCure Pharmaceutical Holding Corp - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The Sustainability rating for Cure Pharmaceutical Holding Corp indicates its transparency towards the United Nations SDGs. Scroll down to the bottom of this page for potential risks for Cure Pharmaceutical Holding Corp based on sector, geography and marketcap. If you work at Cure Pharmaceutical Holding Corp and you wish to use your ESG rating, please contact us.

Cure Pharmaceutical Holding Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 4.0, social score of 3.2 and governance score of 3.2.

SDG Transparency Score for Cure Pharmaceutical Holding Corp 

3.5

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Cure Pharmaceutical Holding Corp 
4.0

Environmental

3.2

Social

3.2

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
.........
1575Vitality Biopharma Inc
3.6
Medium
1575Zhejiang East Asia Pharmaceutical Co Ltd
3.6
Medium
1617Cure Pharmaceutical Holding Corp
3.5
Medium
1617Anika Therapeutics Inc
3.5
Medium
1617Aerovate Therapeutics Inc
3.5
Medium
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Cure Pharmaceutical Holding Corp have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp report the average age of the workforce?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose cybersecurity risks?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp offer flexible work?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp conduct supply chain audits?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose water use targets?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Cure Pharmaceutical Holding Corp have a product recall in the last two years?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose incidents of discrimination?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Cure Pharmaceutical Holding Corp issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose parental leave metrics?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Cure Pharmaceutical Holding Corp involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose its waste policy?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp report according to TCFD requirements?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose energy use targets?

LockedSign up for free to unlock

Does Cure Pharmaceutical Holding Corp disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Cure Pharmaceutical Holding Corp have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Cure Pharmaceutical Holding Corp
These potential risks are based on the size, segment and geographies of the company.

CURE Pharmaceutical Holding Corp., a biopharmaceutical company, focuses on the development and manufacturing of drug formulation and drug delivery technologies to enhance drug safety, efficacy, and patient adherence. It operates through two segments, Cure and Sera Labs. The company's pharmaceutical drug programs include CUREfilm Blue, a sildenafil oral thin film (OTF) for the treatment of erectile dysfunction; CUREfilm Canna, a cannabinoid product with optimized pharmacokinetic profiles using microCURE and CUREfilm technology; CUREfilm Anti-Viral, an orally bio-available anti-viral of an existing therapeutic leveraging existing pre-clinical/clinical safety and toxicity data; and CUREfilm Central Nervous System, a novel dosage form to treat mental health disorders, such as depression, PTSD, addiction disorders, obsessive compulsive disorders, and anxiety. It also sells various wellness products under its distribution partners' brands. In addition, the company develops 50,000IU and Vitamin D3 OTF for oral administration. It has a licensing agreement with Canopy Growth Corporation. The company was founded in 2011 and is headquartered in Oxnard, California.

Sorry!

Failed to process!